A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2002
12/26/2002	US20020197598 Two hybrid assay that detects hiv-1 reverse transcriptase dimerization
12/26/2002	US20020197332 Treatment for ectoparasites
12/26/2002	US20020197327 Taste masked pharmaceutical compositions
12/26/2002	US20020197277 Cell culture system for synthesis of infectious hepatitis C virus
12/26/2002	US20020197276 Heterologous protection induced by immunization with invaplex vaccine
12/26/2002	US20020197269 Pharmaceutical composition for immunomodulation and preparation of vaccines
12/26/2002	US20020197264 Protecting against canine oral papillomavirus (COPV)
12/26/2002	US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes
12/26/2002	US20020197259 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
12/26/2002	US20020197235 Method for short-term and long-term drug dosimetry
12/26/2002	US20020197212 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
12/25/2002	CN1387578A Novel compound F-15078
12/25/2002	CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
12/25/2002	CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002	CN1387529A N-substd. carbamoyloxyalkyl-azolium derivs.
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387443A 联合疫苗组合物 Combined vaccine composition
12/25/2002	CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002	CN1387434A Synergistic combinations of NK1 receptor antagonist and GABA structural analog
12/25/2002	CN1387430A Liver selective therapy
12/25/2002	CN1386545A Antrodia camphorata preparation for protecting liver
12/25/2002	CN1386535A Medicine for treating tuberculosis
12/25/2002	CN1386510A Composition of suppressing infection, and veberage and food contg. same
12/25/2002	CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them
12/25/2002	CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/25/2002	CN1096862C Controlled-release dosage form of azithromycin
12/25/2002	CN1096851C Adjuvant for vaccine compsoition
12/24/2002	US6498254 Antiretroviral compounds and compositions
12/24/2002	US6498241 2-deoxy-isoguanosines isosteric analogues and isoguanosine derivatives as well as their synthesis
12/24/2002	US6498234 Compounds
12/24/2002	US6498187 Fatty acid synthase inhibitors
12/24/2002	US6498183 Substituted indole sulfonamides as anitviral agents
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002	US6498008 Method for detecting swine infertility and respiratory virus
12/24/2002	US6498007 Methods of treatment of disease using adsorbent carriers
12/24/2002	US6497949 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives
12/24/2002	US6497905 Aqueous solubility pharmaceutical formulations
12/24/2002	US6497883 Porcine circovirus recombinant poxvirus vaccine
12/24/2002	US6497882 Virus comprising foreign dna inserted into swinepox virus genome within specified region, which is capable of being expressed in host cell into which virus is introduced
12/24/2002	US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein
12/24/2002	US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis
12/24/2002	CA2252402C Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/24/2002	CA2172955C Liposomal defensins
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2065462C Radiopharmaceutical bacteriostats
12/24/2002	CA2038984C Hydroxymethyl-indolizidines and quinolizidines
12/19/2002	WO2002101412A2 Spray freeze-dried compositions
12/19/2002	WO2002101049A2 Interleukin-18 mutants, their production and use
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002100900A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof
12/19/2002	WO2002100895A2 Antimicrobially active peptide
12/19/2002	WO2002100890A2 Respiratory syncytial virus
12/19/2002	WO2002100874A1 Compounds for binding nucleic acids
12/19/2002	WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/19/2002	WO2002100854A1 Lactone formulations and method of use
12/19/2002	WO2002100853A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100429A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100428A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100424A1 Antiviral composition incorporating lectins
12/19/2002	WO2002100418A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002	WO2002100417A2 Use of glycosaminoglycans for the treatment of hiv-associated nephropathy
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100415A2 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100406A1 Use of yohimbine in the preparation of immunobiologically active drugs
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100402A1 Compositions comprising nitrofurantoin and uva ursi
12/19/2002	WO2002100383A1 Porous sponge-like cellulosic material for treatment of injuries
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002100309A1 Quinolone carboxylic acid compositions and related methods of treatment
12/19/2002	WO2002100189A1 Health feed
12/19/2002	WO2002100152A2 Solution-phase combinatiorial library synthesis and pharmaceutically active compounds produced thereby
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002079475A3 Streptococcus pyogenes antigens and corresponding dna fragments
12/19/2002	WO2002074777A3 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
12/19/2002	WO2002072544A3 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain

1 ... 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 ... 1798